Researchers have developed the downstream section of a new streamlined production method for an emerging virus class.

Oncolytic Virus Drugs Uptake and Pipeline Development Activities . ... Large-scale production and quality control of genetically engineered viruses are technically demanding and costly.

Bristol-Myers Squibb has also done a big oncolytic virus deal, acquiring rights late last year to an “armed virus” targeting cancer from the UK biotech, PsiOxus Therapeutics, worth almost $900 ...

Oncolytic viruses engineered to express the Cas9 editor can downregulate PD-L1 expression ... Future research should focus on developing production cells compatible with the immune system to avoid ...

Oncolytic virotherapy with conditionally replicating viruses is a promising approach for treating advanced cancers. Promiscuous tropism and low tumor transduction have represented limiting issues ...

Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering ...

In a new article published in Nature Medicine, the researchers, led by Hatem Soliman, M.D., share results from a phase 2 clinical trial of the oncolytic virus talimogene laherparepvec (TVEC ...

Oncolytic viruses, once considered medical curiosities, are now cutting-edge tools in the fight against some of the most challenging cancers, like glioblastoma.

Types of Oncolytic Viruses. There are a wide range of oncolytic viral candidates, including both DNA and RNA viruses. 2 Scientists choose between viral candidates based on their application needs.

UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to the oncolytic virus ICVB-1042 ...

The oncolytic virus TG6002 has been engineered to directly kill cancer cells (oncolysis), to enable the production of a chemotherapy agent (5-FU) within the tumor, and to elicit an immune response ...